Announcement on Implementation of Dividend Distribution for 2023
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Implementation of Dividend Distribution for 2023
Filed with SSE ·
Announcement on Implementation of Dividend Distribution for 2023
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Nanjing Well Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Nanjing Well Pharmaceutical
- Announcement on Modification of Shareholding Reduction Plan by Senior Management Member through Auction
- Announcement on Resolutions of 2023 Annual General Meeting
- Announcement on Resolutions of 8th Session of 3rd Board of Supervisors
- Announcement on Resolution of 7th Session of 3rd Board of Supervisors
- Indicative Announcement on Reply to 2-round Letter of Review and Inquiry on Application Documents for Public Issuance of Convertible Corporate Bonds (Revised Edition)
Later from Nanjing Well Pharmaceutical
- Announcement on Resolutions of the 9th Meeting of the 3rd Board of Supervisors
- Announcement on Extending Pledge Period of and Supplementary Pledge of Shares Held by Shareholders with Over 5% Shares
- Announcement on Results of Share Reduction by Senior Management Members through Call Auction
- Report for Q3 2024
- Announcement on the Extension of Share Pledge for Shareholders Holding More Than 5% of Shares
Follow Nanjing Well Pharmaceutical into a list and get an email when it puts out news.
Follow Nanjing Well Pharmaceutical